Publications
166
Citations
2,812
Est. group size
~44
Recurring co-author estimate
Active years
24
Publishing since 2003
Bradley W. Blaser's research focuses on blood cancers (such as acute myeloid leukemia, acute lymphoblastic leukemia, and chronic lymphocytic leukemia) and the biology of the bone marrow 'niche' — the microenvironment of supporting cells that regulates how blood stem cells and leukemia cells grow and survive. His work combines laboratory models (including zebrafish and mesenchymal stromal cell systems), single-cell sequencing, and gene-editing tools like CRISPR to study how these niche interactions influence disease and treatment resistance, alongside some studies analyzing clinical trial data and representation using AI and large language models.
Publication output has grown substantially over the last decade, rising from just a few papers per year in 2017-2019 to a peak of around 40 in 2024, with continued high output into 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T-cell phenotypes in CLL patients treated with ibrutinib.
Open MIND · 2026
- Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T-cell phenotypes in CLL patients treated with ibrutinib.
Zenodo (CERN European Organization for Nuclear Research) · 2026
- Has racial and ethnic representation in oncology clinical trials changed?: A 30-year systematic analysis using artificial intelligence.
Journal of Clinical Oncology · 2026
- <scp>PIEZO1</scp> Activation‐Mediated Generation of Transgene‐Free Long‐Term Hematopoietic Stem Cells
American Journal of Hematology · 2025
- Trends of Authors' Conflicts of Interest in Clinical Trials Published in the <i>Journal of Clinical Oncology</i> : A Large Language Model–Assisted Longitudinal Study
JCO Oncology Practice · 2025
- Vcam1 in endothelial and stromal cells regulates hematopoietic stem cell contact with the niche
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- CRISPR Screen Identifies ENT1 as a Mediator of Decitabine-Induced Myelotoxicity (Abstract ID: 165636)
Journal of Pharmacology and Experimental Therapeutics · 2025
- Analysis of conflicts of interest in clinical trials published in JCO: A large language model-assisted longitudinal study.
Journal of Clinical Oncology · 2025
- 1014 – NICHE CONTACT DURING DEVELOPMENT PROGRAMS HEMATOPOIETIC STEM CELLS
Experimental Hematology · 2025
- 3030 – NICHE INTERACTIONS DURING DEVELOPMENT DOWNREGULATE INFLAMMATORY PATHWAYS IN HEMATOPOIETIC STEM AND PROGENITOR CELLS
Experimental Hematology · 2025
- A novel dll4 enhancer regulates sinusoidal niche-mediated HSC proliferation and maintenance
Blood · 2025
- Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors
JCI Insight · 2024
- In vivo monitoring of leukemia-niche interactions in a zebrafish xenograft model
PLoS ONE · 2024
- Mesenchymal Stromal Cell Expansion in FLT3-ITD+ Zebrafish Treated with Gilteritinib
Blood · 2024
- ALL-R: An Anchoring Score to Predict Relapse in Acute Lymphoblastic Leukemia (ALL) Using a Zebrafish Patient-Derived Xenograft Model
Blood · 2024
- Blood×29
- Journal of Clinical Oncology×5
- Biology of Blood and Marrow Transplantation×3
- Cancer Research×3
- Blood Advances×2
- Gregory K. Behbehani
Medicine · The Ohio State University
- Jean Truxall
Medicine · The Ohio State University
- Brian Giacopelli
Medicine · The Ohio State University
- Jae Yoon Jeon
Medicine · The Ohio State University
- Mehdi Gharghabi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile